The PROTEUS Consortium (Patient-Reported Outcomes Tools: Engaging Users & Stakeholders) and Pfizer Global Medical Grants are collaborating to offer a grant funding opportunity to support the use of patient-reported outcome measures in clinical practice to improve the monitoring and management of patients with cancer.
AstraZeneca has launched the global R&D Postdoctoral Challenge to help accelerate the treatment of complex diseases, including cancer.
Thermo Fisher Scientific is calling for proposals for its Oncomine Clinical Research Grant. The latest request for submissions will award funding for molecular profiling research that helps accelerate the use of genomic sequencing in oncology.
The NYU Grossman School of Medicine Working Group on Compassionate Use and Preapproval Access will be offering a course, Access to Investigational Medical Products: Clinical Trials, Expanded Access, and Right to Try, at the University of Arizona James E. Rogers College of Law, in partnership with Arizona Law’s Health Law and Policy Program.
ALK Positive and LUNGevity Foundation have issued a Request for Application for ALK-positive Lung Cancer Research Awards to be granted in 2022.
The FY22 Defense Appropriations Act is anticipated to provide funding for the Lung Cancer Research Program to support high-impact lung cancer research.
The FDA Oncology Center of Excellence is accepting applied research proposals for five-year research contracts.
The American Association for Cancer Research and Pelotonia established a new grants program funded by The Victoria’s Secret Global Fund for Women’s Cancers to celebrate and foster innovative research in breast and gynecologic cancers.
The American Association for Cancer Research launched two career development awards to further diversity, equity, and inclusion in cancer research: one for basic, translational, or population sciences research, and the other for clinical cancer research.
Thermo Fisher Scientific is accepting submissions for its Oncomine Clinical Research Grant.
